U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07089043) titled 'A Study in Subjects With Neurogenic Orthostatic Hypotension' on July 14.

Brief Summary: This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).

Study Start Date: Sept. 08

Study Type: INTERVENTIONAL

Condition: Neurogenic Orthostatic Hypotension

Intervention: DRUG: CST-3056

Administered as an oral solution

DRUG: Placebo

Administered as an oral solution

Recruitment Status: NOT_YET_RECRUITING

Sponsor: CuraSen Therapeutics, Inc.

Disclaimer: Curated by HT Syndication....